The autonomously cell-penetration bacterial protein YopM as a novel biological therapeutic against rheumatoid arthritis (PA689/13-1)

Basic data for this project

Type of projectIndividual project
Duration at the University of Münster15/11/2011 - 14/11/2014

Description

The project is conducted together with Prof. Dr. T. Pap (UKM) The bacterial protein YopM is an effector protein of Y. enterocolitica and has been identified as a cell-penetzrating bacterial peptide. In all tested cell types the expression of TNFalpha and other pro-inflammatory cytokines is strongly reduced. Here we will assess the possibility to develop YopM as a novel therapeutic for the treatment of rheumatoid arthritis in a transgenic mouse model expressing hTNF.

KeywordsInfektiologie; Zelluläre Mikrobiologie; Rheumatologie; Orthopädie
Funding identifierPA 689/13-1
Funder / funding scheme
  • DFG - Individual Grants Programme

Project management at the University of Münster

Schmidt, Marcus Alexander

Applicants from the University of Münster

Pap, Thomas
Schmidt, Marcus Alexander